Navigation Links
Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer
Date:10/22/2008

ongoing study may support the advancement of picoplatin into a Phase 3 clinical trial for HRPC. Our growing body of safety and efficacy data also supports the potential for additional uses of picoplatin as a combination therapy in the treatment of non-small cell lung and ovarian cancers where platinum and taxane combinations are currently used."

About Picoplatin

Picoplatin has an improved safety profile relative to existing platinum-based cancer therapies and is designed to overcome platinum resistance associated with chemotherapy in solid tumors. It is being studied in multiple cancer indications, combinations and formulations. Picoplatin has been evaluated in more than 750 patients and has demonstrated anti-tumor activity in multiple indications with less severe kidney toxicity (nephrotoxicity) and nerve toxicity (neurotoxicity) than is commonly observed with other platinum chemotherapy drugs.

In addition to the ongoing Phase 2 clinical trial in HRPC, Poniard is evaluating intravenous picoplatin in an ongoing pivotal Phase 3 trial, known as SPEAR (Study of Picoplatin Efficacy After Relapse), in small cell lung cancer. This registration trial currently is being conducted under a Special Protocol Assessment (SPA) from the U.S. Food and Drug Administration and is evaluating overall survival as the primary endpoint. Picoplatin is also being evaluated in a Phase 2 clinical trial in patients with metastatic colorectal cancer. Oral picoplatin is being evaluated in a Phase 1 clinical trial in solid tumors. The oral formulation of picoplatin has the same active pharmaceutical ingredient as the intravenous formulation. Picoplatin has not been approved by any regulatory authority for use in humans.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. For additional information ple
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
2. Poniard Pharmaceuticals Announces Upgrade of Stock Listing to NASDAQ Global Market
3. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
5. Poniard Pharmaceuticals Announces Upcoming Conference Participation
6. Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
7. Poniard Pharmaceuticals Appoints Four New Members to Clinical Advisory Board
8. Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31
9. Poniard Pharmaceuticals Announces Upcoming Conference Participation
10. Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium
11. Poniard Pharmaceuticals Announces Upcoming Conference Participation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...W YORK, Nov. 25 Reportlinker.com a...lable in its catalogue: ,, Brazil Bioethanol M...//www.reportlinker.com/p0165503/Brazil-Bioethanol-...Brazil Bioethanol Market Analysis and Forecasts to...tailed analysis and forecasts of the global bioeth...
(Date:11/24/2009)...vailable in German . , Whether it,s CD pack...gs (Radio Frequency Identification) are increasing... it possible to label objects or goods and identif...priate scanner can read and process the data conta...goods under production conditions of up to 100 deg...
(Date:11/24/2009)... Ambassador to also Visit Detroit , ...Who: David Appia, French Ambassador for Internatio... in France Agency, , , , ,What: Ambassador Appia ...pro-business initiatives adopted by France to furt...dscape for innovation and development., , ,When: A...
(Date:11/24/2009)...A CRUZ, Calif., Nov. 24 Two more p...ter, the nation,s leading online job board and car...rthwestern and Columbia University are now members...ence training Institutions. ,, The job board, ...es in the life sciences. While there are hundreds ...
Breaking Biology Technology:Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2
...emphasis on,safety by regulatory agencies worldwid...nt programs and requires rapid, cost-effective and... appropriately. Expertise,to effect constructive c...P,has already emplaced systems to protect our clie...e regulatory action by the FDA. Throughout the,pro...
...h,s leading MISSION(TM) shRNA ...drich (Nasdaq: SIAL ), a,leading life science com...ly welcomes the Memorial Sloan-Kettering Cancer Ce...a-aldrich.com/rpp ). The RNAi Partnership,Program ...roducts in,Sigma-Aldrich,s functional genomics por...
... have drawn major interest because of their semico...ic properties. Various applications for ZnO nanowi...tion of field effect transistors, light emitting d...lso envisioned as nanogenerators by exploiting the...erties. , Researchers at the McCormick School of ...
Other Biology Technology:Ground Zero Pharmaceuticals Announces Expansion of Regulatory and Product Development Consulting Services 2Ground Zero Pharmaceuticals Announces Expansion of Regulatory and Product Development Consulting Services 3Sigma-Aldrich Welcomes Memorial Sloan-Kettering Cancer Center to the RNAi Partnership Program 2Sigma-Aldrich Welcomes Memorial Sloan-Kettering Cancer Center to the RNAi Partnership Program 3Strong elasticity size effects in ZnO nanowires 2Strong elasticity size effects in ZnO nanowires 3
(Date:11/24/2009)...weakened and flabby arteries from collapsing have ... stents are no longer needed -- once the arteries ...sly, doctors had no choice but to leave them in pl...sity,s Department of Biomedical Engineering has de...arries drugs where they,re needed, then dissolves....
(Date:11/24/2009)... fish food is a matter of debate. A high-profile s...t 50 percent of their carbon from trees and leaves...strial and aquatic ecosystems. , But new researc...not likely to be true. Algae provide a much richer...o research published this week in the Proceedings...
(Date:11/23/2009)...ss. November 23, 2009 Applied mathematicians dis... lancifolia ), a characteristic long leaf with a s...es along the edges. The simple cause of the lily,s...ending during differential growthwas revealed by u...ribbons. , Haiyi Liang, a postdoctoral student a...
Breaking Biology News(10 mins):A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The cause behind the characteristic shape of a long leaf revealed 2Health Expert Dr David Friedman Reveals Which Sweeteners Are Best 56456 1Health Expert Dr David Friedman Reveals Which Sweeteners Are Best 56456 2Health Expert Dr David Friedman Reveals Which Sweeteners Are Best 56456 3Baucus Co Op Plan Would Gut State Laws 3B Consumer Watchdog Report Calls for Prior Approval Rate Regulation in Health Reform Not Deregulation of Stat 56451 1Baucus Co Op Plan Would Gut State Laws 3B Consumer Watchdog Report Calls for Prior Approval Rate Regulation in Health Reform Not Deregulation of Stat 56451 2Baucus Co Op Plan Would Gut State Laws 3B Consumer Watchdog Report Calls for Prior Approval Rate Regulation in Health Reform Not Deregulation of Stat 56451 3Baucus Co Op Plan Would Gut State Laws 3B Consumer Watchdog Report Calls for Prior Approval Rate Regulation in Health Reform Not Deregulation of Stat 56451 4Sharpie 28R 29 Makes Its Mark at Mercedes Benz Fashion Week 56446 1Sharpie 28R 29 Makes Its Mark at Mercedes Benz Fashion Week 56446 2Sharpie 28R 29 Makes Its Mark at Mercedes Benz Fashion Week 56446 3Sharpie 28R 29 Makes Its Mark at Mercedes Benz Fashion Week 56446 4
...f Minnesota have, for the first time, coaxed umbil... type of lung cell. , The cord blood cells differe...veolar cells. These cells are responsible for sec...r sacs in the lungs to remain open, allowing air t...responsible for helping to repair the airway after...
...compound to increase the lifespan of obese mice, a...changes in gene expression patterns found in mice ...d with diabetes, heart disease, and other signific... by investigators at Harvard Medical School and th...hat the small molecule resveratrol has been shown ...
...mammals, birds and amphibians ever produced shows ...nhabit the same geographical areas, says new resea...ts, previous assumptions, the map shows conclusive...on of endangered species from one group, do not ne...new finding has far-reaching implications for cons...
Other Biology News:U of MN researchers turn cord blood into lung cells 2Single molecule extends fat mice lives by reversing gene pathways associated with disease in obese 2Single molecule extends fat mice lives by reversing gene pathways associated with disease in obese 3Single molecule extends fat mice lives by reversing gene pathways associated with disease in obese 4Single molecule extends fat mice lives by reversing gene pathways associated with disease in obese 5Global map shows new patterns of extinction risk 2
Rabbit IgG ELISA Development Kit, SensiFlex with Fluorocillin Green 495/525 from Molecular Probes (Invitrogen)
Bovine BSA, Fluorescein conjugated/tagged from Biosearch Technologies
Sheep Anti-Human CORTISOL BINDING GLOBULIN Polyclonal Antibody, Unconjugated from AbD Serotec
Eosinophil IHC Staining Kit, EoProbe from BioFX Laboratories, Inc.
Biology Products: